GlassScriptPhysician profile
Lucia Corro
NPI 1669472254
$1,068.81
in general payments reported to CMS, 2019-2025
16 companies · $90.04 in 2025
The $90.04 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $29.02 · 2021: $106 · 2022: $232 · 2023: $296 · 2024: $186 · 2025: $90.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $571.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $199.85 | 2019-2023 | Veltassa, Korsuva |
| Astrazeneca Pharmaceuticals LP | $146.23 | 2019-2024 | Farxiga |
| Amgen INC. | $125.65 | 2022-2024 | Tavneos, Krystexxa, Aranesp |
| Otsuka America Pharmaceutical, INC. | $108.45 | 2021-2025 | Jynarque |
| Akebia Therapeutics INC | $93.57 | 2019-2024 | Auryxia, Vafseo |
| Travere Therapeutics, INC. | $79.62 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $72.65 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.03 | 2021-2022 | |
| Scpharmaceuticals INC. | $38.80 | 2025 | |
| Mallinckrodt Hospital Products INC. | $36.92 | 2024 | Acthar |
| Novartis Pharmaceuticals Corporation | $28.14 | 2025 | |
| Aurinia Pharma U.S., INC. | $23.58 | 2022 | |
| Calliditas Therapeutics US INC. | $19.46 | 2023 | Tarpeyo |
| Lilly USA, LLC | $18.90 | 2024 | Jardiance |
| Fresenius USA Marketing, INC. | $16.13 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Opko Pharmaceuticals, LLC | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucia Corro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.